Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26‐week PRONTO‐T1D study

por Klaff, Leslie, Cao, Dachuang, Dellva, Mary Anne, Tobian, Janet, Miura, Junnosuke, Dahl, Dominik, Lucas, Jean, Bue‐Valleskey, Juliana
Publicado 2020

Long-Term Efficacy and Safety of Ultra Rapid Lispro (URLi) in Adults with Type 1 Diabetes: The PRONTO-T1D Extension

por Bue-Valleskey, Juliana, Klaff, Leslie, Cho, Jang Ik, Dellva, Mary Anne, Schloot, Nanette C., Tobian, Janet, Miura, Junnosuke, Dahl, Dominik
Publicado 2021

Novel Once-Weekly Basal Insulin Fc Achieved Similar Glycemic Control With a Safety Profile Comparable to Insulin Degludec in Patients With Type 1 Diabetes

por Kazda, Christof M., Bue-Valleskey, Juliana M., Chien, Jenny, Zhang, Qianyi, Chigutsa, Emmanuel, Landschulz, William, Wullenweber, Paula, Haupt, Axel, Dahl, Dominik
Publicado 2023